Roth Capital Partners is acting as manager.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech Faces Nasdaq Non-Compliance Notice
- Moleculin Biotech’s Earnings Call: Trials and Triumphs
- Moleculin Biotech’s Growth Potential Highlighted by Phase 3 MIRACLE Trial and Strategic Advancements
- Moleculin Biotech Reports Q1 2025 Financial Results
- Moleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year